Meme Peponis’ practice focuses on acquisition and other debt financings, including leveraged loans and high-yield bonds.

She is distinguished as one of the country’s best banking and finance lawyers by Chambers Global, Chambers USA, and The Legal 500 U.S. In 2012, she received the Individual Banking and Finance Award at the Euromoney Legal Media Group Americas Women in Business Law Awards.

Meme joined the firm in 1996 and became a partner in 2006.

Notable Experience

  • Warburg Pincus in the financing for its investments in LabStat, Duravant, CityMD, Gabriel Brothers, Hygiena, Allied Universal, Sotera Health, Wencor Group, Santander Asset Management, Crossmark, Consolidated Precision Products, and Endurance International Group, and various financings for these and other portfolio companies of Warburg Pincus.

  • Honeywell International in the financing relating to its spin-off of Resideo Technologies.

  • Allied Universal in the financing for its approximately $1 billion acquisition of U.S. Security Associates.

  • Consolidated Precision Products in the financing for its acquisition of Selmet.

  • CityMD in the financing for its acquisition of STAT Health.

  • Duravant in the financing for its acquisitions of Key Technology and Wulftec International.

  • JELD-WEN in various financing transactions.

  • Sabre Holdings in various financing transactions.

  • Sotera Health in its $350 million offering of PIK-toggles notes and in the financing for its acquisitions of Nelson Laboratories and Toxikon Europe.

  • McCormick & Company in the financing for its $4.2 billion acquisition of Reckitt Benckiser’s food business.

  • Temasek in the financing for its investment in Global Healthcare Exchange.

  • Hygiena in the financing for its acquisition of DuPont’s global food safety diagnostics business.

  • Electronic Funds Source in connection with financing matters relating to its sale to Wex.

  • Endurance International Group in the financing for its $1.1 billion acquisition of Constant Contact.

  • Allergan in connection with financing matters relating to the $40.5 billion sale of its generics business to Teva.

  • Actavis (now Allergan) in the financing for its $66 billion acquisition of Allergan.

  • Forest Laboratories in the financing for its $2.9 billion acquisition of Aptalis.

  • Medtronic in the financing for its $43 billion acquisition of Covidien.

  • Suntory in the financing for its $16 billion acquisition of Beam.

  • Revolving credit facilities for investment-grade borrowers, including Allergan, McDonald’s, The Hartford, Honeywell, and Voya Financial.

See More

Publications